Le Lézard
Classified in: Health
Subjects: PDT, HSP, LBR, POL

Inside Rx En Español: Company Launches Spanish Language Website for Consumers Seeking Discounts on Prescription Medications


FRANKLIN LAKES, N.J., Jan. 10, 2018 /PRNewswire/ -- Inside Rx, which administers a prescription savings program for the uninsured and underinsured, is helping more people access savings to prescription medications today with the launch of a Spanish-language version of the company's website, https://insiderx.com/es. Inside Rx, a partially owned subsidiary of Express Scripts (NASDAQ:ESRX), provides affordable access to brand and generic medications, delivering an average savings of 40 percent on select brand name prescription medications for the uninsured and those who experience high out-of-pocket drug costs.

Inside Rx En Español: Company Launches Spanish Language Website for Consumers Seeking Discounts on Prescription Medications. Learn more at www.insiderx.com/es.

"Managing one's health condition can be difficult. Combining the high costs of these medications with a language barrier makes it even harder," said Leslie Achter, CEO of Inside Rx. "By making our site available in Spanish, we hope to open the door to needed discounted medications to Spanish-speaking communities."

The Inside Rx discount program instantly provides access to significant savings for more than 70 popular brand-name drugs that treat diabetes, asthma, heart disease, depression, gastrointestinal disorders, gout and other common illnesses. Benefiting from these discounts is easy for eligible patients who only need to present the discount card at one of 40,000 participating pharmacies in the U.S. and Puerto Rico, which includes national chains such as CVS, Kroger Family of Pharmacies and Walgreens. There is no membership fee to obtain the card, which can help patients save hundreds or even thousands of dollars a year.  

Inside Rx offers important discounts for medications that treat chronic conditions, such as diabetes, which disproportionately affect the Hispanic population. According to American Diabetes Association, prevalence rates of diagnosed and undiagnosed Hispanics can be as high as 18 percent in some culturally distinct Hispanic groups, compared to 10 percent for non-Hispanic whites.

The Inside Rx prescription savings program provides access to deep discounts on select brand-name diabetes medications, including insulin, as well as medications that treat other conditions commonly associated with diabetes, such as high cholesterol and blood pressure. People using the Inside Rx card can save an average of $180 on featured brand insulin medications.

A complete list of the medications and participating pharmacies, as well as instructions for downloading the card and eligibility information, can be found in Spanish at https://insiderx.com/es.

About Inside Rx
Headquartered in Franklin Lakes, New Jersey, Inside Rx provides affordable access to prescription medication for the uninsured and those navigating the changing healthcare landscape.

Powered by our parent company, Express Scripts, and working collaboratively across the pharmacy supply chain, Inside Rx delivers access to a broad list of branded medications that treat many common, chronic health conditions.

Visit www.insiderx.com, or follow us @Inside_Rx on Twitter, to learn more.

Media Contact:
Jennifer Luddy
[email protected]
(201) 269-6402

 

SOURCE Inside Rx


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...



News published on and distributed by: